SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-032368
Filing Date
2014-05-08
Accepted
2014-05-08 17:57:47
Documents
1
Period of Report
2014-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5512
  Complete submission text file 0001209191-14-032368.txt   7080
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DR SUITE 385 SAN DIEGO CA 92130
Business Address
Brady Todd C (Reporting) CIK: 0001579179 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 14826381